A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Author(s) -
Robyn J. Barst,
D. Dunbar Ivy,
Guillermo Gaitan,
András Szatmári,
Andrzej Rudziński,
Alberto E. García,
B.K.S. Sastry,
Tomás Pulido,
Gary Layton,
Marjana Serdarevic-Pehar,
David Wessel
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.016667
Subject(s) - sildenafil , medicine , placebo , pulmonary hypertension , population , adverse effect , anesthesia , dose ranging study , hemodynamics , placebo controlled study , cardiology , double blind , alternative medicine , environmental health , pathology
Safe, effective therapy is needed for pediatric pulmonary arterial hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom